Meta-analysisindependent cross-checkabstract checked★ key study I-LIFE-111 standard review
Slow-breathing devices for high blood pressure
Efficacy of device-guided breathing for hypertension in blinded, randomized, active-controlled trials: a meta-analysis of individual patient data.
Overview
Landman GW et al.. JAMA Intern Med 2014 · PMID 25222103 · DOI 10.1001/jamainternmed.2014.4336
When compared fairly with sham devices or music, slow-breathing devices did not lower blood pressure.
Does the study support the specific claim? No · Methodological quality: high
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Test DGB for hypertension.
- How was the study done?
IPD meta-analysis of blinded trials.
- How many people, animals or samples were studied?
3 trials with IPD.
- What was actually found?
No BP reduction.
- How large was the observed effect?
SBP +2.2 mmHg (-2.7 to 7.0) favouring control.
- What do the results mean in everyday life?
Breathing exercises relax, but do not replace blood pressure treatment.
- What are the study's limitations?
Few trials.
- What does it say about Elawady's specific claim?
Limits 'beneficial for health' to well-being.
- Do the results apply to Germany and Europe?
Applies; same physiology.
- What can explicitly not be concluded from this study?
Effects of other breathing techniques.
Scientific in-depth review
1. Full reference
- Authors
- Landman GW et al.
- Journal
- JAMA Intern Med
- Year
- 2014
- Identifier
- PMID 25222103 DOI 10.1001/jamainternmed.2014.4336
- Verification
- verified – PubMed efetch 2026-10-26; Crossref update-to/updated-by check
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
not stated in abstract
2. Research question
Does device-guided slow breathing lower blood pressure when compared with sham or music?
3. Study design and population
- Study design
- Meta-analysis – Individual patient data meta-analysis of blinded RCTs with active control
- Population
Adults with hypertension
- Country
International
- Period
not stated in abstract
- Sample size
5 eligible studies; IPD from 3
- Inclusion and exclusion criteria
not stated in abstract
4. Methods and endpoints
- Exposure / intervention
Device-guided breathing (>=4 weeks)
- Comparator
Music therapy or sham device
- Endpoints
Office blood pressure
- Statistical methods
Linear mixed models
5. Actual results
- Results
Office systolic BP 2.2 mmHg (95% CI -2.7 to 7.0) in favour of control; diastolic 0.2 mmHg (-2.8 to 3.1) in favour of DGB; no significant effect.
- Absolute risks
not reported
- Authors' conclusion
DGB did not significantly lower office blood pressure compared with sham or music; no recommendation for hypertension treatment.
6. Strengths
- Blinded active-controlled trials only
- IPD
7. Weaknesses
- IPD missing for 2 of 5 trials
- Short follow-up
8. Risk of bias
- Orienting tool
- AMSTAR 2
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Incomplete IPD.
9. Assessment of the statistical interpretation
Null result with CI excluding large benefits; see stats/I-LIFE-111_breathing.py.
10. Relevance to the specific claim
Limits health claims: when properly controlled, slow breathing did not lower blood pressure.
11. Independent contrary findings
12. Transferability to Germany and Europe
Universal biology; applies in Europe and Egypt.
13. Overall methodological judgement
Contradicts disease-treatment claims for breathing; not the relaxation part.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | high |
| Risk of bias | some concerns |
| Precision of results | moderate |
| Directness | direct |
| Reproducibility | partly replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
15. Linked fact checks
- Deep (slow) breathing is beneficial for health. – Studies contradicting or limiting the claim